Bharat Parenterals Ltd said its subsidiary, Innoxel Lifesciences, has received five observations from the United States Food and Drug Administration (USFDA) following a recent USFDA inspection at its Vadodara facility.
India is steadily emerging as a global leader in using artificial intelligence in healthcare, thanks to its strong digital growth, increasing health awareness, and rising investments in health technology. As AI becomes a part of everyda...
Merck has secured a key step forward as the Merck KEYTRUDA FDA priority review gains momentum in bladder cancer treatment. The US Food and Drug Administration has granted priority review for KEYTRUDA and KEYTRUDA QLEX, both evaluated in...
India’s ammonia rule is tightening the availability of a key raw material for pharmaceutical companies, after the government directed that surplus ammonia from urea plants be reserved primarily for fertilizer production.
India is set to take a major step toward improving end-of-life support as the Indian Council of Medical Research rolls out a palliative care study across multiple states. Announced today, this initiative aims to address a long-standing gap in the...
India’s CDSCO prior intimation mechanism is now live, marking a shift in how drug makers begin early-stage manufacturing for research. The Central Drugs Standard Control Organisation has rolled out the system from April 21, 2026, replacing the...
NCR’s fake Mounjaro problem is growing fast—and most people don’t see it coming. In fact, it is no longer limited to shady corners of the market. It’s now tied to a Rs 70 lakh cache of counterfeit injections recently uncovered, pointing to...
In a significant step toward transforming pediatric critical care, Aster CMI Hospital today announced the launch of PEARL (Pediatric Emergency and Advanced Response for Liver Care) – Karnataka’s first dedicated Pediatric Liver Intensive Care Unit...
Indian oncology medicine manufacturers are witnessing a clear disconnect between rapid scientific innovation — including targeted therapies, biosimilars, next-generation sequencing (NGS), minimal residual disease assays, and immuno-oncology treatm...
OneSource Speciality Pharma has said that its partner, Orbicular Pharmaceutical Technologies, along with a US-based front-end partner, has received tentative approval from the U.S. Food and Drug Administration for a generic version of semaglutid...
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")